BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Rosiglitazone, rs7903146, MYC, T cell receptor signaling pathway, Arthritis, Heart)
Bookmark Forward

QuickView for verapamil (compound)


Genetic Markers

Most Correlated Genes

  1. CYP2A7
  2. CSNK2A1
  3. SCN5A
  4. CA1
  5. AQP8
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. heterocyclic compound binding
  2. PUJANA_BRCA1_PCC_NETWORK
  3. PILON_KLF1_TARGETS_DN
  4. regulation of nitrogen compound metabolic process
  5. DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Broad Connectivity Map (CMAP 2.0) compound database
  2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
  3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
  4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
  5. Drug Matrix In Vivo Toxicogenomic Study - Rat Heart [Codelink]
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Verapamil ameliorates proximal tubular epithelial cells apoptosis and fibrosis in diabetic kidney.
  2. Verapamil in the treatment of reversible cerebral vasoconstriction syndrome: A systematic review.
  3. A Dose-Finding Study to Guide Use of Verapamil as an Adjunctive Therapy in Tuberculosis.
  4. Fluid-solid coupling numerical simulation of the effects of different doses of verapamil on cancello…
  5. Contribution analysis of metabolic tissues on systemic exposure of an active metabolite after oral a…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Study of Verapamil in Refractory Epilepsy
  2. Bioequivalence Study Of Verapamil
  3. Development and Clinical Application of [11C]Verapamil-PET
  4. Drug-Drug Interaction Between Colchicine and Verapamil ER
  5. Trial of Verapamil in Chronic Rhinosinusitis
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.